Current Drug Targets - Inflammation & Allergy
Continued as: Inflammation & Allergy - Drug Targets
Volume , Issues,
ISSN: 1568-010X (Online)
ISSN: 1568-010X (Print)
This journal supports open access
ISSN: 1568-010X (Online)
ISSN: 1568-010X (Print)
This journal supports open access
Contents
Current Drug Targets - Inflammation & Allergy , Volume 3 - Number 1
Modulation of Innate Immune Responses in the Treatment of Sepsis and Pneumonia
, 3(1): 11 - 17Marcus J. Schultz and Tom van der Poll
DOI: 10.2174/1568010043483962
Drugs that Target Lipoxygenases and Leukotrienes as Emerging Therapies for Asthma and Cancer
, 3(1): 19 - 33Candace D. Poff and Michael Balazy
DOI: 10.2174/1568010043483917
T-Cell-Mediated Signalling in Immune, Inflammatory and Angiogenic Processes: The Cascade of Events Leading to Inflammatory Diseases
, 3(1): 35 - 42Claudia Monaco, Evangelos Andreakos, Serafim Kiriakidis, Marc Feldmann and Ewa Paleolog
DOI: 10.2174/1568010043483881
Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
, 3(1): 43 - 61G. Coruzzi, A. Menozzi and G. Dobrilla
DOI: 10.2174/1568010043483971
Antiviral Therapy for Chronic Hepatitis B: A Review
, 3(1): 63 - 70Kazuhiro Hanazaki
DOI: 10.2174/1568010043483908
The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases
, 3(1): 87 - 96M. Mizuno and B. P. Morgan
DOI: 10.2174/1568010043483890
Thrombin: A Potential Proinflammatory Mediator in Neurotrauma and Neurodegenerative Disorders
, 3(1): 105 - 114Z. Suo, B. A. Citron and B. W. Festoff
DOI: 10.2174/1568010043483953
Subject Index to Volume 2
, 3(1): 117 - 119Bentham Science Publishers
DOI: 10.2174/1568010043483926
Webmaster Contact: info@benthamscience.net